Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic

Mukherji, Reetu; Marshall, John L.

doi:10.1007/s11864-021-00888-3

Cited by 6 publications

(6 citation statements)

References 123 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Endoscopic procedure: During the COVID-19 pandemic restrictions there were a significant drop in elective procedures such as screening and diagnostic colonoscopies. Some studies reported a 50% drop in screening and diagnostic colonoscopy procedures[ 9 , 10 , 21 , 24 , 45 , 47 , 49 , 82 ]. This translates to a considerable drop in early diagnosis and endoscopic procedure for T1 lesions amenable to endoscopic resections such as polypectomy, endoscopic mucosal resections or endoscopic submucosal dissection[ 9 , 10 , 21 , 24 , 45 , 47 , 49 , 82 ].…”

Section: Management Of Colorectal Cancermentioning

confidence: 99%

“…The main aim of treatment is to minimize trauma to the patients, reduce hospital stay and to prevent COVID-19 infection. Respiratory screening should be done before surgery to rule out COVID-19 infection[ 9 , 73 , 79 , 82 , 88 ]. Endoscopic colonic stenting using self-expanding metallic stents should first be attempted in patients with obstruction.…”

Section: Management Of Colorectal Cancermentioning

confidence: 99%

“…Endoscopic colonic stenting using self-expanding metallic stents should first be attempted in patients with obstruction. A successful endoscopic colonic stenting relieves obstruction, which in turn allows commencement of neoadjuvant chemotherapy that may downstage the tumor[ 9 , 73 , 79 , 82 , 88 ]. In patients with low rectal tumor, stenting should be avoided as it may cause incontinence and tenesmus[ 9 ].…”

Section: Management Of Colorectal Cancermentioning

confidence: 99%

See 2 more Smart Citations

Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic

Akbulut¹,

Hargura²,

Garzali³

et al. 2022

WJCC

View full text Add to dashboard Cite

Management of colorectal cancer (CRC) was severely affected by the changes implemented during the pandemic, and this resulted in delayed elective presentation, increased emergency presentation, reduced screening and delayed definitive therapy. This review was conducted to analyze the impact of the coronavirus disease 2019 (COVID-19) pandemic on management of CRC and to identify the changes made in order to adapt to the pandemic. We performed a literature search in PubMed, Medline, Index Medicus, EMBASE, SCOPUS, Reference Citation Analysis ( ) and Google Scholar using the following keywords in various combinations: Colorectal cancer, elective surgery, emergency surgery, stage upgrading, screening, surveillance and the COVID-19 pandemic. Only studies published in English were included. To curtail the spread of COVID-19 infection, there were modifications made in the management of CRC. Screening was limited to high risk individuals, and the screening tests of choice during the pandemic were fecal occult blood test, fecal immunochemical test and stool DNA testing. The use of capsule colonoscopy and open access colonoscopy was also encouraged. Blood-based tests like serum methylated septin 9 were also encouraged for screening of CRC during the pandemic. The presentation of CRC was also affected by the pandemic with more patients presenting with emergencies like obstruction and perforation. Stage migration was also observed during the pandemic with more patients presenting with more advanced tumors. The operative therapy of CRC was altered by the pandemic as more emergencies surgeries were done, which may require exteriorization by stoma. This was to reduce the morbidity associated with anastomosis and encourage early discharge from the hospital. There was also an initial reduction in laparoscopic surgical procedures due to the fear of aerosols and COVID-19 infection. As we gradually come out of the pandemic, we should remember the lessons learned and continue to apply them even after the pandemic passes.

show abstract

Section: Management Of Colorectal Cancermentioning

confidence: 99%

Section: Management Of Colorectal Cancermentioning

confidence: 99%

Section: Management Of Colorectal Cancermentioning

confidence: 99%

See 1 more Smart Citation

Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic

Akbulut¹,

Hargura²,

Garzali³

et al. 2022

WJCC

View full text Add to dashboard Cite

show abstract

“…Additionally, the pandemic has led to a widespread deferral of elective procedures, including cancer screenings and surveillance colonoscopies, which are critical for the early detection and management of oncological diseases [ 20 ]. Furthermore, there has been a noticeable disruption in the continuity of care for cancer patients, as many have experienced postponed surgeries or altered chemotherapy protocols, impacting patient outcomes [ 21 ].…”

Section: Introductionmentioning

confidence: 99%

Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions—A Single-Center Retrospective Study

Balan,

Secosan,

Sorop

et al. 2024

Medicina

View full text Add to dashboard Cite

Background and Objectives: Our aim was to perform a retrospective analysis of the volume of cervical screening tests, the number of patients treated with an excision method, and the incidence of invasive and non-invasive cervical during a pandemic and pre-pandemic period of 24 months. Materials and Methods: The study compared 404 patients who underwent cervical cone biopsy for cervical cancer. The study examined patients’ specimens based on histopathological characteristics and categorized cervical lesions based on pap smear. Results: There was a statistically significant age difference between the two study periods. The mean difference was 32 years before the pandemic and 35 years during the pandemic (p-value > 0.05). The biggest patient loss ratio identified by age group was in the 50–59-year group, with a 14.53% loss in the pre-pandemic period and a 9.1% loss in the pandemic period. In the pandemic period, patients from rural areas presented in the clinical trial with a lower rate of 39.52% (83 patients) vs. 60.47% (127 patients) in urban areas. A higher percentage of patients experiencing cervicorrhagia as a clinical manifestation in the pandemic period vs. the pre-pandemic period, with an increase in more severe lesions in the pandemic period, had a statistical significance of 8% more newly diagnosed compared to the pre-pandemic period. Conclusions: The addressability of the patients during the COVID period was not affected in a drastic way in our study. We encountered a decrease in appointments in the age group of 50–59 years and a decrease in patients with rural residence. In our study, we found an increase in cervical bleeding as a reason for consultation in the pandemic period with a higher lesion degree, both on a pap smear and on a cervical biopsy.

show abstract

“…In particular, the necessity of continuing appropriate screening is paramount. Research has been conducted to determine whether delays in the diagnosis and treatment of colorectal cancer impact treatment outcomes, and whether there are viable alternatives when screening is delayed [14,15]. Some studies have reported that treatment delays in colorectal cancer during the COVID-19 pandemic have led to increased mortality rates [16].…”

Section: Introductionmentioning

confidence: 99%

Influence of the COVID-19 Pandemic on the Treatment Patterns and Outcomes of Colorectal Cancer

Park

2023

Ewha Med J

View full text Add to dashboard Cite

Over the past 3 years, the COVID-19 pandemic has posed significant challenges to the healthcare system, leading to delays in the diagnosis and treatment of various diseases due to the need for social distancing measures. Colorectal cancer has not been immune to these disruptions, and research in various countries has explored the impact of COVID-19 on the diagnosis and treatment of colorectal cancer. One notable consequence has been the postponement of colorectal cancer screenings, potentially resulting in disease progression, which can adversely affect surgical and oncological outcomes. Furthermore, the treatment approach for colorectal cancer may vary depending on the extent of disease progression and the healthcare policies implemented in response to the COVID-19 pandemic. In this systematic review, we examine treatment strategies, surgical outcomes, and oncological variables across multiple studies focusing on colorectal cancer treatment during the COVID-19 pandemic. The purpose of this analysis was to assess how medical policies enacted in response to the COVID-19 pandemic have influenced the outcomes of colorectal cancer treatment. We hope that this review will provide valuable insights and serve as a foundational resource for developing guidelines to address potential medical crises in the future.

show abstract

Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic

Cited by 6 publications

References 123 publications

Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic

Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic

Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions—A Single-Center Retrospective Study

Influence of the COVID-19 Pandemic on the Treatment Patterns and Outcomes of Colorectal Cancer

Contact Info

Product

Resources

About